These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10453 related articles for article (PubMed ID: 11448060)

  • 1. Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.
    Konduri SD; Tasiou A; Chandrasekar N; Nicolson GL; Rao JS
    Clin Exp Metastasis; 2000; 18(4):303-8. PubMed ID: 11448060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
    Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.
    Konduri SD; Tasiou A; Chandrasekar N; Rao JS
    Int J Oncol; 2001 Jan; 18(1):127-31. PubMed ID: 11115549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.
    Lakka SS; Konduri SD; Mohanam S; Nicolson GL; Rao JS
    Clin Exp Metastasis; 2000; 18(3):239-44. PubMed ID: 11315097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas.
    Tasiou A; Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Obeyesekere M; Rao JS
    Int J Oncol; 2001 Sep; 19(3):591-7. PubMed ID: 11494041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.
    Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC
    Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion].
    Zhong R; Huang RB; Song SJ
    Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
    Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
    J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.
    Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
    Med Oncol; 2010 Sep; 27(3):867-75. PubMed ID: 19763915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
    Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.
    Yanamandra N; Kondraganti S; Gondi CS; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Int J Cancer; 2005 Jul; 115(6):998-1005. PubMed ID: 15723303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.
    Ivanciu L; Gerard RD; Tang H; Lupu F; Lupu C
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):310-6. PubMed ID: 17138934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
    Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
    Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
    Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 523.